Por qué la reducción de daños y la reforma de las políticas de drogas se necesitan mutuamente


Por qué la reducción de daños y la reforma de las políticas de drogas se necesitan mutuamente

17 febrero 2016

Gloria Lai (IDPC) realiza un breve repaso de la reforma de las políticas de drogas con miras a la Sesión Especial de la Asamblea General de la ONU (UNGASS) sobre el problema mundial de las drogas. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

In response to HIV epidemics amongst people who inject drugs, harm reduction measures have been rolled out in varying degrees in most countries in Asia over the past two decades. During the same period, many governments began claiming that they adopt a health-based approach to drug use.

However, policy responses to drug use in Asia (as in the rest of the world) have remained overwhelmingly focused on punishment, ranging from criminalization to corporal punishment and compulsory detention centres (regarded as ‘rehabilitation centres’ but providing no evidence-based treatment interventions and leading to human rights violations including forced labor, physical and sexual abuse).

Impeded by such brutally punitive legal environments, the coverage of harm reduction measures remains inadequate across the region – and, as a result, HIV and hepatitis epidemics amongst people who inject drugs remain a serious public health concern in many countries.

The existence of drug treatment services that are based on scientific evidence, voluntary, tailored to individual needs, and informed by evidence-based assessments of drug dependence is rare. It has become apparent that it is not just harm reduction measures that are needed, but also drug policies that are driven by the philosophy of harm reduction—that is, focusing on reducing the harms related to drug use rather than on reducing drug use itself.

In the lead up to the UN General Assembly Special Session (UNGASS) on the world drug problem in April 2016, member states from the Americas, Europe and Africa, along with an ever-increasing number of UN agencies, are advocating for a reorientation in drug policies towards public health, human rights and development instead of the longstanding focus on law enforcement responses.

For at least 40 years since then US President Richard Nixon declared a ‘war on drugs’, Asian governments have zealously ramped up law enforcement operations to seize drugs and arrest suspects, and passed laws to exact harsh penalties on anyone engaged in drug-related activities, even the death penalty as a mandatory sentence in Iran, Singapore and Malaysia. They did not spare people who use drugs, believing that tough punishment would be an effective deterrent.

But it hasn’t worked, and levels of drug use and the volume and diversity of drugs available in Asia has only increased, with East and Southeast Asia representing one of the largest markets for synthetic drugs in the world.

Instead, these policies have directly contradicted efforts to implement harm reduction measures in Asia, yet governments have refused to discuss the ineffectiveness and negative consequences of the ‘war on drugs’ and stubbornly cling tounrealistic goals of achieving a drug-free society.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Creative Commons Drug reporter